Filter
359
Filtered Results: 359
Text search:
inactivated
vaccines
Featured
Recommendations
44
New Publications
105
Language
Document type
No document type
174
Guidelines
91
Studies & Reports
39
Manuals
20
Fact sheets
19
Strategic & Response Plan
7
Situation Updates
5
Training Material
3
Resource Platforms
1
Countries / Regions
Global
11
Germany
11
India
11
South Africa
10
Nigeria
8
Latin America and the Carribbean
7
Pakistan
7
Sierra Leone
6
Syria
6
Philippines
6
Ethiopia
6
Nepal
5
Afghanistan
5
Tanzania
5
Kenya
4
Ukraine
4
Chile
4
Uganda
4
Namibia
4
Rwanda
3
Africa
3
Middle East and North Africa
3
Western and Central Europe
3
Russia
3
Yemen
3
Ecuador
3
Myanmar / Burma
3
Malawi
2
Venezuela
2
Congo, Democratic Republic of
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
East and Southern Africa
2
Bangladesh
2
Papua New Guinea
2
Zambia
2
Liberia
2
North Macedonia
1
Colombia
1
Lesotho
1
Turkey
1
Gambia
1
China
1
Niger
1
Peru
1
Zimbabwe
1
Jordan
1
Paraguay
1
Bolivia
1
Argentina
1
Lebanon
1
Brazil
1
Egypt
1
Libya
1
Bhutan
1
Botswana
1
Indonesia
1
Iraq
1
Somalia
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Guidelines
31
COVID-19
21
Drugs & Medical Equipment
17
Vaccine-preventable Diseases
15
Studies & Reports
13
Policies
11
Statistics
10
Immunization
9
Countries
7
Policies & Guidelines HIV & TB
7
General Guidelines
6
Hepatitis
5
Rabies
5
Humanitarian Crisis
5
Disease Prevention & Control
5
Infection Control & Prevention (IPC)
4
Yellow Fever
4
Women & Child Health
4
Information, Education and Communication (IEC)
4
General Guidelines
4
Maternal Health
4
Demograhic Health Surveys DHS
3
WASH
3
HIV & STI
3
Communicable Diseases
2
Paediatrics
2
Child Health
2
Dermatology
2
Diarrhoeal Disease/Cholera
2
Capacity Building
2
Other
2
Respiratory Infections
2
Surgery & Anaesthesia
2
Communicable Diseases
2
NTDs & Others
2
Dengue
2
Neonatal Care
2
Pharmacy & Technology
1
Hand Hygiene
1
Humanitarian Aid
1
Monitoring & Evaluation
1
Cervical Cancer
1
MPOX - Monkeypox
1
Virology
1
Pediatrics
1
NCD
1
Hemorrhagic Fever
1
Community Health
1
Needs Assessment
1
Gynaecology & Obstetrics
1
Non-communicable Diseases
1
Laboratory Quality Assurance
1
Water
1
Reproductive Health
1
Toolboxes
Action Plans, Policies & Response
18
Inactivated COVID-19 Vaccines
13
Immunization Guidelines
11
Communication Material
9
Country specific documents
7
Access & Strategy
7
Booster Doses
7
Vaccination
6
Infection Control General
6
Biontech/Pfizer Comirnaty
6
Essential Medicines & Devices Lists
6
Health Care Systems
6
Outbreak Prevention & Control
5
Laboratory Guidance
5
Vaccination
5
Blood Supply
5
Disease Prevention & Control
5
Context & Facts
5
Situation Reports & Updates
5
IPC
4
Social Worker
4
Public Health
4
Prevention & Preparedness
4
For General Public & Community
4
For Health Worker
4
Physical Distancing
4
Fair Allocation & Ethical Aspects
4
Covaxin
4
Guidelines & Manuals
4
Clinical Aspects & Diagnostics
4
Miscellaneous
4
Infection Control
4
Volunteers
4
Vaccination
4
Treatment Guidelines
3
Assessment & Studies
3
Agriculture & Veterinary
3
Vaccines & Immunization
3
Yellow Fever
3
Children & Adolescents
3
Laboratory & Sampling
3
Scientific & Research Studies
3
Educational Settings
3
Workplace
3
Moderna
3
Rational use of Medicine
3
Studies & Reports
3
Preparedness & Prevention
3
Gynaecology / Obstetrics
2
Ebola Prevention & Control
2
Surveillance
2
Clinical Aspects
2
Clinical Guidelines
2
Key Resources
2
Influenza Prevention & Control
2
Cholera Prevention & Control
2
Health & Refugee
2
Medical professionals
2
Infection Prevention & Hygiene
2
Clinical Aspects
2
COVID-19 Information
2
For Pregnant Women
2
Clinical Guidelines
2
SARS-CoV-2 Variants
2
Vaxzevria (Astra Zeneca)
2
Johnson & Johnson
2
Research & Pipeline
2
Essential Medicines
2
Supply Chain & Store Management
2
General documents One Health
2
General
2
MPOX - Monkeypox
2
MPOX - Monkeypox
2
Clinical Guidelines
2
Assessment & Response
2
Nutrition
2
Reports & Studies Children HIV
2
Context & Facts
2
War & Conflict
1
Public Health
1
Rapid Response
1
Biosafety
1
ART Drug Resistance
1
Male Circumcision
1
Surveillance
1
Clinical Aspects, Treatment & Prevention
1
Europe
1
Treatment & Prevention
1
Yellow Fever Prevention & Control
1
Country specific
1
Prevention & Control
1
Surgery & Rehabilitation
1
Pediatrics
1
Opportunistic Infections
1
WASH
1
Assessment & Response
1
Context, Facts & Travel Advice
1
Dengue
1
Infection Control
1
Hepatitis
1
Namibia
1
HIV
1
Children/Adolescents Mental Disorders
1
Research
1
Ebola
1
Public Health
1
Cholera
1
Workplace
1
General
1
Climate & Health
1
Laboratory
1
Context & Facts
1
Clinical Guidelines
1
Studies
1
Context & Facts, Travel Advice
1
Hand Hygiene
1
Poster & Infographics
1
Risk Communication & Community Engagement
1
Diagnostics & Laboratory Guidance
1
Surveillance & Contact tracing
1
Covid-19 & the One Health Approach
1
Covid-19 & Climate Change
1
For Parents & Children
1
Training, others
1
Country Specific
1
Prison & Detention
1
Medical & Community Masks
1
Hospital Readiness/Essential Health Services
1
COVID-19 Vaccination
1
Non-pharmaceutical interventions (NPIs)
1
Preparedness, Response & Risk Communication
1
Logistics & Supply
1
Genomic sequencing
1
COVAX Initiative
1
Chile
1
Prices and Patents
1
Model Formulary
1
Pharmacy Practice
1
General Guidelines for Rational Use
1
Pharmacovigilance
1
Waste Managment
1
Situation Reports & Updates
1
Zoonoses
1
Infectious Diseases
1
Health Impact & Climate Change
1
Emergency health kits
1
Humanitarian Aid Guidelines
1
MPOX -Monkeybox Prevention & Control
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Information & Education Material (IEC)
1
General Information & Methodology
1
Women
1
Clinical Aspects & Diagnosis
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
Autism
1
Situation Reports & Updates
1
Technical Information
1
Malawi
1
TB & Prisoners
1
Education of students & professionals
1
Training
1
Assessment & Response
1
Research & Access
1
Dengue Prevention & Control
1
Technical Information
1
Clinical Guidelines
1
HIV / AIDS
1
Testing Guidelines
1
TB/HIV Coinfection
1
Chikungunya Prevention & Control
1
Zika Prevention & Control
1
WASH
1
WASH
1
Laboratory
1
Psychosocial Support
1
Paediatrics
1
Marburg Virus Situation Reports
1
Key Resources
1
Preparedness & Prevention
1
Global Health Financing
1
Laboratory & Diagnostics
1
Kenya
1
Pregnant women
1
Meningitis & Encephalitis
1
Public Health
1
In many countries neonatal tetanus is responsible for half of all neonatal deaths due to vaccine-preventable diseases and for almost 14% of al¡ infant deaths. It is estimated that in the 1970s more than 10,000 newborns died annually from neonatal tetanus in the Americas. Neonatal tetanus is prevent...
This guide provides a comprehensive overview of essential information related to immunization, including technical information about vaccines, a review of immunization program management best practices, guidance on the delivery of immunization services, monitoring and evaluation, disease surveillanc...
Responding to a polio outbreak. Guidelines
recommended
The occurrence of a case of wild polio in a previously polio free area as presently in Syria, whether through importation, laboratory accident, or mutation of vaccine virus (VDPV), should be considered a public health emergency, that requires a rapid and high quality response as utmost priority
Update 2021; Immunization, Vaccines and Biologicals
Humanitarian emergencies, regardless of type and cause, have a number of common risk factors for communicable diseases inextricably linked to excess risk of morbidity and mortality which can come from vaccine–preventable diseases (VPDs). The reduction of VPDs is a significant aim of public-health ...
The main objectives of the SOPs are to: (i) establish standards and timelines for response activities; and (ii) guide national governments and GPEI partners in key support functions.
This new version of the SOPs presents overall response requirements for dealing with type 1, 2 and 3 poliovirus fo...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
The WHO Global Polio Eradication Initiative (GPEI)’s new Polio Eradication and Endgame Strategic Plan targets the end of all kinds of polioviruses by 2018, including the wild and rare vaccine-related strains which cause paralysis among thousands of children worldwide. The plan is focused on develo...
Emerg Infect Dis. 2020 Jul [date cited]. https://doi.org/10.3201/eid2607.200915
Infection control instructions call for use of alcohol-based hand rub solutions to inactivate severe acute respiratory syndrome coronavirus 2. We determined the virucidal activity of World Health Organization–recommen...
Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk of severe COVID-19, NPI are the most effective public health interventions against...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines ...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
Many of the countries in the European Region receiving refugees from Ukraine are already offering vaccination services to children and adults. This is important to mitigate the risk of COVID-19 transmission among people travelling or living in close quarters, to protect the refugees from diseases th...
Supplement to: Guidance on vaccination and prevention of vaccine-preventable disease outbreaks for countries hosting refugees from Ukraine, April 2022 update
This document provides: • information on how to obtain vaccination documentation remotely (intended for refugees from Ukraine and intern...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
